Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol pharmacokinetics study comparing HFA-152a and HFA-134a inhalers in healthy adults
NL-OMON60576Phase 1Completed
- Sponsor
- GSK
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of salbutamol (2 arms), sponsored by GSK. Started May 2024; status: completed.
02
Drugs
salbutamol
Beyond the preview
Go deeper on NL-OMON60576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60576.